Total Payments
$3,079
2021 Payments
$455.66
Companies
24
Transactions
222
Medicare Patients
1,816
Medicare Billing
$136,127
Payment Breakdown by Category
Food & Beverage$3,056 (99.2%)
Education$23.30 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,056 | 219 | 99.2% |
| Education | $23.30 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $821.36 | 58 | $0 (2021) |
| Novo Nordisk Inc | $631.89 | 55 | $0 (2021) |
| AbbVie Inc. | $199.01 | 15 | $0 (2021) |
| Lilly USA, LLC | $191.29 | 15 | $0 (2021) |
| Astellas Pharma US Inc | $133.76 | 6 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $119.31 | 7 | $0 (2021) |
| GlaxoSmithKline, LLC. | $108.65 | 7 | $0 (2021) |
| Mylan Specialty L.P. | $104.81 | 7 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $99.46 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $98.26 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $455.66 | 30 | AbbVie Inc. ($142.58) |
| 2020 | $512.95 | 36 | Amgen Inc. ($174.46) |
| 2019 | $783.58 | 64 | Amgen Inc. ($191.90) |
| 2018 | $710.76 | 46 | Amgen Inc. ($238.33) |
| 2017 | $616.49 | 46 | Amgen Inc. ($150.41) |
All Payment Transactions
222 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes | ||||||
| 09/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Obesity | ||||||
| 08/10/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Neuroscience | ||||||
| 07/29/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: VACCINES | ||||||
| 06/10/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.75 | General |
| 05/27/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Obesity | ||||||
| 05/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Neuroscience | ||||||
| 04/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Gastroenterology | ||||||
| 04/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Neuroscience | ||||||
| 04/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $14.35 | General |
| 04/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Gastroenterology | ||||||
| 04/08/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Diabetes | ||||||
| 03/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Diabetes | ||||||
| 03/05/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.74 | General |
| 03/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 02/18/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 02/11/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 15 | 826 | 1,318 | $110,616 | $66,266 |
| 2020 | 17 | 990 | 1,548 | $135,855 | $69,861 |
Total Patients
1,816
Total Services
2,866
Medicare Billing
$136,127
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 450 | $67,500 | $42,436 | 62.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 104 | $10,400 | $7,220 | 69.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 30 | $5,850 | $4,500 | 76.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 111 | 111 | $6,660 | $2,527 | 37.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 15 | 15 | $2,350 | $1,883 | 80.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 93 | 93 | $2,790 | $1,769 | 63.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 119 | 134 | $6,700 | $1,541 | 23.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 58 | 58 | $1,740 | $1,002 | 57.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 36 | 90 | $2,250 | $873.90 | 38.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 37 | 37 | $930.00 | $758.66 | 81.6% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 22 | 22 | $770.00 | $624.14 | 81.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 40 | $1,496 | $440.80 | 29.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 38 | 100 | $500.00 | $328.00 | 65.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 17 | 17 | $510.00 | $293.55 | 57.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 14 | 17 | $170.00 | $68.34 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 141 | 508 | $76,200 | $40,635 | 53.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 108 | $10,800 | $6,202 | 57.4% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 36 | 42 | $9,450 | $4,345 | 46.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 15 | 20 | $7,960 | $3,824 | 48.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 115 | 115 | $6,900 | $3,190 | 46.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 129 | 153 | $7,650 | $2,031 | 26.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 107 | 107 | $3,210 | $1,961 | 61.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 95 | 95 | $2,850 | $1,605 | 56.3% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 48 | 48 | $1,680 | $1,403 | 83.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 11 | 11 | $1,380 | $1,287 | 93.3% |
About Dr. James Clinton, D.O
Dr. James Clinton, D.O is a Internal Medicine healthcare provider based in Clinton Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558340356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Clinton, D.O has received a total of $3,079 in payments from pharmaceutical and medical device companies, with $455.66 received in 2021. These payments were reported across 222 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,056).
As a Medicare-enrolled provider, Clinton has provided services to 1,816 Medicare beneficiaries, totaling 2,866 services with total Medicare billing of $136,127. Data is available for 2 years (2020–2021), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Clinton Township, MI
- Active Since 01/11/2006
- Last Updated 04/26/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558340356
Products in Payments
- Aimovig (Biological) $386.87
- Saxenda (Drug) $234.87
- Prolia (Biological) $194.44
- Victoza (Drug) $181.59
- UBRELVY (Drug) $156.23
- EVENITY (Biological) $136.67
- XIFAXAN (Drug) $130.70
- Tymlos (Biological) $92.47
- Ozempic (Drug) $92.29
- Yupelri (Drug) $90.81
- VESICARE (Drug) $90.15
- EMGALITY (Drug) $81.02
- SHINGRIX (Biological) $80.57
- TUDORZA PRESSAIR (Drug) $71.03
- BEVESPI AEROSPHERE (Drug) $70.06
- TRULICITY (Drug) $69.07
- Androgel (Drug) $56.43
- AJOVY (Drug) $56.31
- Repatha (Biological) $46.58
- JANUVIA (Drug) $44.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clinton Township
Edin Basic, D.o, D.O
Internal Medicine — Payments: $8,777
Internal Medicine $8,777
Linda Lu Kosal, D.o, D.O
Internal Medicine — Payments: $8,569
Internal Medicine $8,569
Bryan Eastes, Md, MD
Internal Medicine — Payments: $7,031
Internal Medicine $7,031
Dr. Harjeet Jhajj, D.o, D.O
Internal Medicine — Payments: $4,551
Internal Medicine $4,551
Dr. Amy Calati, D.o, D.O
Internal Medicine — Payments: $3,876
Internal Medicine $3,876
Elmoataz Ibrahim, M.d, M.D
Internal Medicine — Payments: $3,429
Internal Medicine $3,429